Skip to main content
. 2020 Nov 10;6(5):1330–1340. doi: 10.1016/j.bioactmat.2020.10.019

Fig. 3.

Fig. 3

(A) Gene silencing ability of RGDfC-Se@siSox2 or RGDfC-Se@siNC in HepG2 cells. The concentration of siRNA was 200 nM **p < 0.01 vs control. (B) Viabilities of HepG2 cells treated with RGDfC-Se@siSox2 or RGDfC-Se@siNC for 48 h **p < 0.01 vs RGDfC-Se@siNC. (C) Cell viability of LO2 cells incubated with RGDfC-Se@siSox2 for 48 h.